Literature DB >> 7983000

Distinct roles of the intracellular domains of transforming growth factor-beta type I and type II receptors in signal transduction.

T Okadome1, H Yamashita, P Franzén, A Morén, C H Heldin, K Miyazono.   

Abstract

Transforming growth factor-beta (TGF-beta) transduces signals through binding to type I (T beta R-I) and type II (T beta R-II) serine/threonine kinase receptors. T beta R-I requires T beta R-II for ligand binding, whereas T beta R-II requires T beta R-I for signaling. We generated two different chimeric TGF-beta receptors, i.e. T beta R-1.2 containing the extracellular domain of T beta R-I and the intracellular domain of T beta R-II, and T beta R-2.1 containing the extracellular domain of T beta R-II and the intracellular domain of T beta R-I. T beta R-2.1 bound 125I-TGF-beta 1 alone, whereas T beta R-1.2 bound the ligand only in the presence of T beta R-II or T beta R-2.1. When transfected into a mutant mink lung epithelial cell line that lacks functional T beta R-II, T beta R-II cDNA, but not T beta R-2.1 cDNA, restored the responsiveness to TGF-beta 1 with regard to transcriptional activation of plasminogen activator inhibitor-1 gene promoter and 12-O-tetradecanoylphorbol-13-acetate-responsive elements. In a mutant mink lung epithelial cell line lacking T beta R-I, T beta R-I cDNA stimulated promoter activity, but the T beta R-1.2 cDNA did not. T beta R-2.1 formed an oligomer with T beta R-II when transfected into COS cells, but the complex did not transduce the signal after ligand stimulation. On the other hand, co-transfection of T beta R-1.2 and T beta R-2.1 cDNAs restored the responsiveness to TGF-beta 1. These results indicate that an interaction between the intracellular regions of T beta R-I and T beta R-II, triggered by ligand binding to the extracellular domains of these receptors, leads to efficient signal transduction by TGF-beta.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7983000

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Advances in gene therapy of liver cirrhosis: a review.

Authors:  W J Dai; H C Jiang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

Review 2.  Reversal of tumor-induced immunosuppression by TGF-beta inhibitors.

Authors:  Slawomir Wojtowicz-Praga
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

3.  TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs.

Authors:  Tao Huang; Laurent David; Valentín Mendoza; Yong Yang; Maria Villarreal; Keya De; LuZhe Sun; Xiaohong Fang; Fernando López-Casillas; Jeffrey L Wrana; Andrew P Hinck
Journal:  EMBO J       Date:  2011-03-18       Impact factor: 11.598

4.  A chimeric serine/threonine kinase receptor system reveals the potential of multiple type II receptors to cooperate with transforming growth factor-beta type I receptor.

Authors:  M Muramatsu; J Yan; K Eto; T Tomoda; R Yamada; K Arai
Journal:  Mol Biol Cell       Date:  1997-03       Impact factor: 4.138

5.  ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma.

Authors:  G H Su; R Bansal; K M Murphy; E Montgomery; C J Yeo; R H Hruban; S E Kern
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

6.  Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.

Authors:  K Luo; H F Lodish
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

7.  ELL Protein-associated Factor 2 (EAF2) Inhibits Transforming Growth Factor β Signaling through a Direct Interaction with Smad3.

Authors:  Xing Liu; Zhu Chen; Gang Ouyang; Tieshan Song; Huageng Liang; Wei Liu; Wuhan Xiao
Journal:  J Biol Chem       Date:  2015-09-14       Impact factor: 5.157

8.  Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors.

Authors:  L Gilboa; A Nohe; T Geissendörfer; W Sebald; Y I Henis; P Knaus
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

9.  Ras-mediated suppression of TGFbetaRII expression in intestinal epithelial cells involves Raf-independent signaling.

Authors:  N M Bulus; H M Sheng; N Sizemore; S M Oldham; J V Barnett; R J Coffey; D R Beauchamp; J A Barnard
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

10.  Cerebral malaria: insights from host-parasite protein-protein interactions.

Authors:  Aditya Rao; Mayil K Kumar; Thomas Joseph; Gopalakrishnan Bulusu
Journal:  Malar J       Date:  2010-06-09       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.